FDAnews
www.fdanews.com/articles/157130-vaccine-focused-pfizer-licenses-out-tb-drug

Vaccine-Focused Pfizer Licenses Out TB Drug

July 17, 2013
Pfizer has handed over the reins of its sutezolid program to Rockville, Md.-based Sequella. The TB drug stands to treat drug-resistant and aggressively drug-resistant TB, as well as HIV-associated TB infections. First, however, Sequella must complete clinical testing and marketing.
The Pharma Times